Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.

[1]  G. Parmigiani,et al.  Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.

[2]  J. Church.  Familial adenomatous polyposis. , 2009, Surgical oncology clinics of North America.

[3]  A. Kong,et al.  Chemoprevention of familial adenomatous polyposis in ApcMin/+ mice by phenethyl isothiocyanate (PEITC) , 2008, Molecular carcinogenesis.

[4]  P. Propping,et al.  Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome , 2008, The Journal of pathology.

[5]  H. Vasen.  Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer) * , 2007, Alimentary pharmacology & therapeutics.

[6]  A. Kong,et al.  Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. , 2007, Cancer research.

[7]  Esa Läärä,et al.  Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. , 2007, Gastroenterology.

[8]  Z. Cohen,et al.  Does early colectomy increase desmoid risk in familial adenomatous polyposis? , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  P. Propping,et al.  Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP) , 2007, Human mutation.

[10]  D. Bonneau,et al.  Colorectal Adenomatous Polyposis Associated with MYH Mutations: Genotype and Phenotype Characteristics , 2007, Diseases of the colon and rectum.

[11]  G. Sakorafas,et al.  Abdominal desmoid tumors. , 2007, Surgical oncology.

[12]  A. Caughey,et al.  Gynecologic Cancer Prevention in Lynch Syndrome/Hereditary Nonpolyposis Colorectal Cancer Families , 2007, Obstetrics and gynecology.

[13]  J. Cucherousset,et al.  Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer. , 2007, Anticancer research.

[14]  V. O'shea,et al.  Base-excision repair of oxidative DNA damage , 2007, Nature.

[15]  T. Senda,et al.  Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia , 2007, Medical Molecular Morphology.

[16]  A. Dziki,et al.  Chemoprevention of colorectal cancer – a new target needed? , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[17]  N. McC. Mortensen,et al.  Should ileal pouch–anal anastomosis include mucosectomy? , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[18]  H. Perdry,et al.  Estimating cancer risk in HNPCC by the GRL method , 2007, European Journal of Human Genetics.

[19]  M. Ballo,et al.  Optimizing treatment of desmoid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Gallinger,et al.  Germline MYH mutations in a clinic‐based series of Canadian multiple colorectal adenoma patients , 2007, Journal of surgical oncology.

[21]  M. Trivett,et al.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer , 2007, Familial Cancer.

[22]  A. Cats,et al.  Is surveillance of the small bowel indicated for Lynch syndrome families? , 2007, Gut.

[23]  J. Gisbert,et al.  Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  D. Chung,et al.  Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  J. Cheadle,et al.  MUTYH-associated polyposis--from defect in base excision repair to clinical genetic testing. , 2007, DNA repair.

[26]  G. Capellá,et al.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.

[27]  J. Mecklin,et al.  Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome , 2007, International journal of cancer.

[28]  David I. K. Martin,et al.  Inheritance of a cancer-associated MLH1 germ-line epimutation. , 2007, The New England journal of medicine.

[29]  M. Nieuwenhuis,et al.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. , 2007, Critical reviews in oncology/hematology.

[30]  Sanyuan Hu,et al.  Laparoscopic versus open proctocolectomy with ileal pouch‐anal anastomosis , 2007, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[31]  P. Propping,et al.  Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? , 2006, Pediatric blood & cancer.

[32]  J. Saurin,et al.  Familial adenomatous polyposis predisposes to pathologic exposure of the stomach to bilirubin. , 2006, Surgery.

[33]  S. Gruber,et al.  ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Phillips,et al.  A 10‐year review of surgery for desmoid disease associated with familial adenomatous polyposis , 2006, The British journal of surgery.

[35]  J. Disario,et al.  Video capsule endoscopy compared with standard endoscopy for the evaluation of small-bowel polyps in persons with familial adenomatous polyposis (with video). , 2006, Gastrointestinal endoscopy.

[36]  G. Petersen,et al.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. , 2006, JAMA.

[37]  G. Giles,et al.  Large genomic alterations in hMSH2 and hMLH1 in early‐onset colorectal cancer: identification of a large complex de novo hMLH1 alteration , 2006, Clinical genetics.

[38]  J. Jass.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. , 2006, World journal of gastroenterology.

[39]  R. Gryfe.  Clinical implications of our advancing knowledge of colorectal cancer genetics: inherited syndromes, prognosis, prevention, screening and therapeutics. , 2006, The Surgical clinics of North America.

[40]  Harry Campbell,et al.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.

[41]  P. Chappuis,et al.  Prevalence of MYH germline mutations in Swiss APC mutation‐negative polyposis patients , 2006, International journal of cancer.

[42]  C. Boland,et al.  Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications , 2006, European Journal of Human Genetics.

[43]  G. Giles,et al.  Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  J. Hopper,et al.  Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[45]  W. Foulkes,et al.  Familial Adenomatous Polyposis , 2006, The American Journal of Gastroenterology.

[46]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[47]  L. Burgart.  Testing for defective DNA mismatch repair in colorectal carcinoma: a practical guide. , 2005, Archives of pathology & laboratory medicine.

[48]  C. Gupta,et al.  High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis. , 2005, Archives of pathology & laboratory medicine.

[49]  James Church,et al.  The Utility of Capsule Endoscopy Small Bowel Surveillance in Patients with Polyposis , 2005, The American Journal of Gastroenterology.

[50]  J. Prendergast,et al.  Germline susceptibility to colorectal cancer due to base-excision repair gene defects. , 2005, American journal of human genetics.

[51]  M. Goggins,et al.  Prevention and management of duodenal polyps in familial adenomatous polyposis , 2005, Gut.

[52]  H. Lynch,et al.  Hereditary colorectal cancer-part II. , 2005, Current problems in surgery.

[53]  J. Potter,et al.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.

[54]  S. Gallinger,et al.  Transduodenal Resection of Peri-Ampullary Lesions , 2005, World Journal of Surgery.

[55]  H. Lynch,et al.  Hereditary colon cancer--part I. , 2005, Current problems in surgery.

[56]  C. Lines,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[57]  J. Vermeesch,et al.  Large deletions of the APC gene in 15% of mutation‐negative patients with classical polyposis (FAP): A Belgian study , 2005, Human mutation.

[58]  M. Imamura,et al.  New Pancreas-preserving Total Duodenectomy Technique , 2005, World Journal of Surgery.

[59]  S. Gallinger,et al.  Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis , 2004, Journal of Clinical Pathology.

[60]  L. Lipton,et al.  Colorectal cancer and inherited mutations in base-excision repair. , 2004, The Lancet. Oncology.

[61]  R. Russell,et al.  Pylorus‐preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis , 2004, The British journal of surgery.

[62]  W. Curran,et al.  Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. , 2004, Anticancer research.

[63]  K. Aben,et al.  More Differences Between HNPCC-related and Sporadic Carcinomas From the Endometrium as Compared to the Colon , 2004, The American journal of surgical pathology.

[64]  H. Morreau,et al.  Survival after adjuvant 5‐FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer , 2004, International journal of cancer.

[65]  J. Disario,et al.  Surveillance and treatment of periampullary and duodenal adenomas in familial adenomatous polyposis , 2004, Current treatment options in gastroenterology.

[66]  R. Écochard,et al.  Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  R. Weksberg,et al.  Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. , 2004, Gastroenterology.

[68]  S. Narayan,et al.  Role of APC and DNA mismatch repair genes in the development of colorectal cancers , 2003, Molecular Cancer.

[69]  R. Burt.  Gastric fundic gland polyps. , 2003, Gastroenterology.

[70]  T. Iwama,et al.  A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[71]  M. Ducreux,et al.  Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. , 2003, Cancer research.

[72]  J. Church,et al.  Risk of Rectal Cancer in Patients After Colectomy and Ileorectal Anastomosis for Familial Adenomatous Polyposis , 2003, Diseases of the colon and rectum.

[73]  J. Church,et al.  Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). , 2003, Diseases of the colon and rectum.

[74]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[75]  C. Boland,et al.  Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status , 2002, International journal of cancer.

[76]  A. Sauvanet,et al.  Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis , 2002, Gut.

[77]  B. Levin,et al.  A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis , 2002, Gut.

[78]  A. Spigelman,et al.  Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study , 2002, Gut.

[79]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[80]  R. Hultcrantz,et al.  Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. , 2001, Gastroenterology.

[81]  J. Mecklin,et al.  The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. , 2001, Gynecologic oncology.

[82]  J. Gebert,et al.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families , 2001, Gut.

[83]  C. Herfarth,et al.  Duodenal adenomatosis in familial adenomatous polyposis coli , 2001, International Journal of Colorectal Disease.

[84]  H. Järvinen,et al.  Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. , 2000, Gastroenterology.

[85]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[86]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[87]  B. Alman,et al.  A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta‐catenin in the desmoid tumor , 2000, Clinical genetics.

[88]  K. Neale,et al.  Desmoid tumours complicating familial adenomatous polyposis , 1999, The British journal of surgery.

[89]  H. Järvinen,et al.  Management of Duodenal Adenomas in 98 Patients with Familial Adenomatous Polyposis , 1999, Endoscopy.

[90]  C. Boland,et al.  Mismatch repair proficiency and in vitro response to 5-fluorouracil. , 1999, Gastroenterology.

[91]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[92]  S. Powell,et al.  Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene , 1998, Gut.

[93]  Z. Cohen,et al.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.

[94]  Erwin G. Van Meir,et al.  Brain tumor-polyposis syndrome: two genetic diseases? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[96]  G. Thomas,et al.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. , 1995, Human molecular genetics.

[97]  J. Jass,et al.  The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. , 1994, Anticancer research.

[98]  P. Propping,et al.  Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer , 1994, The Lancet.

[99]  T. Iwama,et al.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. , 1993, Annals of surgery.

[100]  M. Sivak,et al.  Gastroduodenal polyps in patients with familial adenomatous polyposis , 1992, Diseases of the colon and rectum.

[101]  H. Järvinen,et al.  Rectal cancer risk in patients treated for familial adenomatous polyposis , 1992, The British journal of surgery.

[102]  F. Sellner,et al.  Investigations on the significance of the adenoma‐carcinoma sequence in the small bowel , 1990, Cancer.

[103]  A. Spigelman,et al.  UPPER GASTROINTESTINAL CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS , 1989, The Lancet.

[104]  V. Fazio,et al.  Desmoid Tumors in Familial Polyposis Coli , 1986, Annals of surgery.

[105]  A. H. Harkness,et al.  Oral penicillin in gonorrhoea. , 1946, Lancet.

[106]  A. Spigelman,et al.  Gastroduodenal lesions in familial adenomatous polyposis , 2010, Surgery Today.

[107]  P. Battista,et al.  Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis , 2007, Journal of surgical oncology.

[108]  D. Chang,et al.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside , 2007, Familial Cancer.

[109]  T. Tuohy,et al.  Gonadal mosaicism and familial adenomatous polyposis , 2007, Familial Cancer.

[110]  R. Eeles,et al.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) , 2007, Familial Cancer.

[111]  A. Wierzbicki,et al.  Limitations of non-ceruloplasmin-bound copper in routine clinical practice. , 2007, Gut.

[112]  J. Burn.  The current status of chemoprevention in FAP: Commentary , 2006 .

[113]  J. Church.  In which patients do I perform IRA, and why? , 2005, Familial Cancer.

[114]  C. Sempoux,et al.  Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited , 2005, Familial Cancer.

[115]  S. Bülow,et al.  The history of familial adenomatous polyposis , 2005, Familial Cancer.

[116]  R. Phillips,et al.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis , 2005, Familial Cancer.

[117]  S. Gallinger,et al.  Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma , 2004, Familial Cancer.

[118]  S. Woolf,et al.  AMERICAN GASTROENTEROLOGICAL ASSOCIATION Colorectal Cancer Screening and Surveillance : Clinical Guidelines and Rationale — Update Based on New Evidence , 2003 .

[119]  S. Olschwang,et al.  Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. , 2000, The Journal of clinical endocrinology and metabolism.

[120]  E. Dimagno.  Pancreatic cancer: clinical presentation, pitfalls and early clues. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[121]  Z. Cohen,et al.  Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. , 1996, American journal of surgery.

[122]  M. Bisgaard,et al.  Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate , 1994, Human mutation.